
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Ferroptosis as a Novel Therapeutic Target for Friedreich’s Ataxia
M. Grazia Cotticelli, Shujuan J. Xia, Daniel W. Lin, et al.
Journal of Pharmacology and Experimental Therapeutics (2019) Vol. 369, Iss. 1, pp. 47-54
Open Access | Times Cited: 117
M. Grazia Cotticelli, Shujuan J. Xia, Daniel W. Lin, et al.
Journal of Pharmacology and Experimental Therapeutics (2019) Vol. 369, Iss. 1, pp. 47-54
Open Access | Times Cited: 117
Showing 1-25 of 117 citing articles:
Ferroptosis: molecular mechanisms and health implications
Daolin Tang, Xin Chen, Rui Kang, et al.
Cell Research (2020) Vol. 31, Iss. 2, pp. 107-125
Open Access | Times Cited: 2563
Daolin Tang, Xin Chen, Rui Kang, et al.
Cell Research (2020) Vol. 31, Iss. 2, pp. 107-125
Open Access | Times Cited: 2563
The Metabolic Underpinnings of Ferroptosis
Jiashuo Zheng, Marcus Conrad
Cell Metabolism (2020) Vol. 32, Iss. 6, pp. 920-937
Open Access | Times Cited: 948
Jiashuo Zheng, Marcus Conrad
Cell Metabolism (2020) Vol. 32, Iss. 6, pp. 920-937
Open Access | Times Cited: 948
Mitochondria regulation in ferroptosis
Hai Wang, Can Liu, Yongxin Zhao, et al.
European Journal of Cell Biology (2019) Vol. 99, Iss. 1, pp. 151058-151058
Closed Access | Times Cited: 479
Hai Wang, Can Liu, Yongxin Zhao, et al.
European Journal of Cell Biology (2019) Vol. 99, Iss. 1, pp. 151058-151058
Closed Access | Times Cited: 479
Nrf2 and Ferroptosis: A New Research Direction for Neurodegenerative Diseases
Xiaohua Song, Dingxin Long
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 434
Xiaohua Song, Dingxin Long
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 434
Organelle-specific regulation of ferroptosis
Xin Chen, Rui Kang, Guido Kroemer, et al.
Cell Death and Differentiation (2021) Vol. 28, Iss. 10, pp. 2843-2856
Open Access | Times Cited: 254
Xin Chen, Rui Kang, Guido Kroemer, et al.
Cell Death and Differentiation (2021) Vol. 28, Iss. 10, pp. 2843-2856
Open Access | Times Cited: 254
Ferroptosis and Its Potential Role in Human Diseases
Han Chu, Yuanyuan Liu, Rongji Dai, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 229
Han Chu, Yuanyuan Liu, Rongji Dai, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 229
Achieving Life through Death: Redox Biology of Lipid Peroxidation in Ferroptosis
Hülya Bayır, Tamil S. Anthonymuthu, Yulia Y. Tyurina, et al.
Cell chemical biology (2020) Vol. 27, Iss. 4, pp. 387-408
Open Access | Times Cited: 213
Hülya Bayır, Tamil S. Anthonymuthu, Yulia Y. Tyurina, et al.
Cell chemical biology (2020) Vol. 27, Iss. 4, pp. 387-408
Open Access | Times Cited: 213
Mitochondrial dysfunction in the development and progression of neurodegenerative diseases
Joseph Johnson, Elizabeth Mercado‐Ayón, Yesica Mercado-Ayon, et al.
Archives of Biochemistry and Biophysics (2020) Vol. 702, pp. 108698-108698
Closed Access | Times Cited: 194
Joseph Johnson, Elizabeth Mercado‐Ayón, Yesica Mercado-Ayon, et al.
Archives of Biochemistry and Biophysics (2020) Vol. 702, pp. 108698-108698
Closed Access | Times Cited: 194
Ferroptosis in liver disease: new insights into disease mechanisms
Jing Wu, Yi Wang, Rongtao Jiang, et al.
Cell Death Discovery (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 178
Jing Wu, Yi Wang, Rongtao Jiang, et al.
Cell Death Discovery (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 178
Identification of Frataxin as a regulator of ferroptosis
Jing Du, Yi Zhou, Yanchun Li, et al.
Redox Biology (2020) Vol. 32, pp. 101483-101483
Open Access | Times Cited: 174
Jing Du, Yi Zhou, Yanchun Li, et al.
Redox Biology (2020) Vol. 32, pp. 101483-101483
Open Access | Times Cited: 174
The Role of NCOA4-Mediated Ferritinophagy in Ferroptosis
Naiara Santana-Codina, Ajami Gikandi, Joseph D. Mancias
Advances in experimental medicine and biology (2021), pp. 41-57
Closed Access | Times Cited: 173
Naiara Santana-Codina, Ajami Gikandi, Joseph D. Mancias
Advances in experimental medicine and biology (2021), pp. 41-57
Closed Access | Times Cited: 173
Molecular mechanisms of ferroptosis and their involvement in brain diseases
Inês Costa, Daniel José Barbosa, Sofia Benfeito, et al.
Pharmacology & Therapeutics (2023) Vol. 244, pp. 108373-108373
Open Access | Times Cited: 168
Inês Costa, Daniel José Barbosa, Sofia Benfeito, et al.
Pharmacology & Therapeutics (2023) Vol. 244, pp. 108373-108373
Open Access | Times Cited: 168
Iron-sulfur cluster deficiency can be sensed by IRP2 and regulates iron homeostasis and sensitivity to ferroptosis independent of IRP1 and FBXL5
Erdem M. Terzi, Vladislav O. Sviderskiy, Samantha Alvarez, et al.
Science Advances (2021) Vol. 7, Iss. 22
Open Access | Times Cited: 130
Erdem M. Terzi, Vladislav O. Sviderskiy, Samantha Alvarez, et al.
Science Advances (2021) Vol. 7, Iss. 22
Open Access | Times Cited: 130
Fighting age-related orthopedic diseases: focusing on ferroptosis
Qin Ru, Yusheng Li, Wenqing Xie, et al.
Bone Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 95
Qin Ru, Yusheng Li, Wenqing Xie, et al.
Bone Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 95
Role and mechanism of ferroptosis in neurological diseases
Mengmeng Ou, Ying Jiang, Yingying Ji, et al.
Molecular Metabolism (2022) Vol. 61, pp. 101502-101502
Open Access | Times Cited: 80
Mengmeng Ou, Ying Jiang, Yingying Ji, et al.
Molecular Metabolism (2022) Vol. 61, pp. 101502-101502
Open Access | Times Cited: 80
Srs11‐92, a ferrostatin‐1 analog, improves oxidative stress and neuroinflammation via Nrf2 signal following cerebral ischemia/reperfusion injury
Yuhua Chen, Wei He, Hong Wei, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 29, Iss. 6, pp. 1667-1677
Open Access | Times Cited: 61
Yuhua Chen, Wei He, Hong Wei, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 29, Iss. 6, pp. 1667-1677
Open Access | Times Cited: 61
Research on ferroptosis as a therapeutic target for the treatment of neurodegenerative diseases
Yi Wang, Meng-nan Lv, Weijiang Zhao
Ageing Research Reviews (2023) Vol. 91, pp. 102035-102035
Open Access | Times Cited: 50
Yi Wang, Meng-nan Lv, Weijiang Zhao
Ageing Research Reviews (2023) Vol. 91, pp. 102035-102035
Open Access | Times Cited: 50
Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects
Qin Ru, Yusheng Li, Lin Chen, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 50
Qin Ru, Yusheng Li, Lin Chen, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 50
Omaveloxolone: a groundbreaking milestone as the first FDA-approved drug for Friedreich ataxia
Federica Pilotto, Deepika M. Chellapandi, Hélène Puccio
Trends in Molecular Medicine (2024) Vol. 30, Iss. 2, pp. 117-125
Open Access | Times Cited: 31
Federica Pilotto, Deepika M. Chellapandi, Hélène Puccio
Trends in Molecular Medicine (2024) Vol. 30, Iss. 2, pp. 117-125
Open Access | Times Cited: 31
Ferroptosis mechanisms and regulations in cardiovascular diseases in the past, present, and future
Wenxi Fang, Saiyang Xie, Wei Deng
Cell Biology and Toxicology (2024) Vol. 40, Iss. 1
Open Access | Times Cited: 22
Wenxi Fang, Saiyang Xie, Wei Deng
Cell Biology and Toxicology (2024) Vol. 40, Iss. 1
Open Access | Times Cited: 22
The Nrf2 induction prevents ferroptosis in Friedreich's Ataxia
Piergiorgio La Rosa, Sara Petrillo, Riccardo Turchi, et al.
Redox Biology (2020) Vol. 38, pp. 101791-101791
Open Access | Times Cited: 122
Piergiorgio La Rosa, Sara Petrillo, Riccardo Turchi, et al.
Redox Biology (2020) Vol. 38, pp. 101791-101791
Open Access | Times Cited: 122
Friedreich ataxia- pathogenesis and implications for therapies
Martin B. Delatycki, Sanjay I. Bidichandani
Neurobiology of Disease (2019) Vol. 132, pp. 104606-104606
Open Access | Times Cited: 119
Martin B. Delatycki, Sanjay I. Bidichandani
Neurobiology of Disease (2019) Vol. 132, pp. 104606-104606
Open Access | Times Cited: 119
Emerging Opportunities To Manipulate Metal Trafficking for Therapeutic Benefit
Elizabeth W. Hunsaker, Katherine J. Franz
Inorganic Chemistry (2019) Vol. 58, Iss. 20, pp. 13528-13545
Open Access | Times Cited: 89
Elizabeth W. Hunsaker, Katherine J. Franz
Inorganic Chemistry (2019) Vol. 58, Iss. 20, pp. 13528-13545
Open Access | Times Cited: 89
The Multifaceted Regulation of Mitochondria in Ferroptosis
Hao Wu, Fengli Wang, Na Ta, et al.
Life (2021) Vol. 11, Iss. 3, pp. 222-222
Open Access | Times Cited: 87
Hao Wu, Fengli Wang, Na Ta, et al.
Life (2021) Vol. 11, Iss. 3, pp. 222-222
Open Access | Times Cited: 87
Targeting ferroptosis: A novel therapeutic strategy for the treatment of mitochondrial disease-related epilepsy
Amanda Kahn-Kirby, Akiko Amagata, Céline I. Maeder, et al.
PLoS ONE (2019) Vol. 14, Iss. 3, pp. e0214250-e0214250
Open Access | Times Cited: 76
Amanda Kahn-Kirby, Akiko Amagata, Céline I. Maeder, et al.
PLoS ONE (2019) Vol. 14, Iss. 3, pp. e0214250-e0214250
Open Access | Times Cited: 76